Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology
EraGen Biosciences' develops Multicode diagnostic panel
May 10th, 2006
EraGen Biosciences Inc., a venture-backed biotechnology company focused on automating molecular diagnostics, announced the development of an innovative MultiCode diagnostic panel to address a range of clinical and research applications for respiratory diseases to include SARS and avian flu. Because of its advantages over competing methods, MultiCode tests received the recent Frost & Sullivan Award for Product Innovation of the Year. "We are very confident in MultiCode products. Our successful collaborations with respected global clinical laboratories and business partners are proof that MultiCode is a very accurate and rapid means of detection," said Irene Hrusovsky,...
Source: Vaccine Weekly (2006-05-10)
|
